SANA Sana Biotechnology Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SANA

Price (delayed)

$3.08

Market cap

$922.03M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.76

Enterprise value

$934.5M

?
Relative Growth: Rel. Growth: 11
Relative Strength: Rel. Strength: 29
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 7
Highlights
The equity has grown by 30% from the previous quarter and by 26% YoY
The EPS is up by 28% year-on-year and by 18% since the previous quarter
SANA's quick ratio is down by 42% YoY but it is up by 9% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://sana.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of SANA

SANA stock price

How has the Sana Biotechnology stock price performed over time
Intraday
-7.51%
1 week
5.48%
1 month
-21.23%
1 year
-5.52%
YTD
-24.32%
QTD
-11.75%

Financial performance

How have Sana Biotechnology's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$218.75M
Net income
-$211.82M
Gross margin
N/A
Net margin
N/A
The net income is up by 16% year-on-year and by 12% since the previous quarter
The operating income has grown by 15% YoY and by 12% from the previous quarter

Price vs fundamentals

How does SANA's price correlate with its fundamentals

Growth

What is Sana Biotechnology's growth rate over time

Valuation

What is Sana Biotechnology stock price valuation
P/E
N/A
P/B
5.55
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 28% year-on-year and by 18% since the previous quarter
SANA's P/B is 67% above its 5-year quarterly average of 3.6
The equity has grown by 30% from the previous quarter and by 26% YoY

Efficiency

How efficient is Sana Biotechnology business performance
The company's return on invested capital fell by 38% YoY but it rose by 9% QoQ
The return on equity has grown by 17% since the previous quarter but it has declined by 17% year-on-year
Sana Biotechnology's ROA has increased by 16% from the previous quarter and by 5% YoY

Dividends

What is SANA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SANA.

Financial health

How did Sana Biotechnology financials performed over time
The company's total assets is 56% higher than its total liabilities
The current ratio is down by 44% YoY but it is up by 7% from the previous quarter
SANA's quick ratio is down by 42% YoY but it is up by 9% from the previous quarter
SANA's debt is 52% smaller than its equity
The debt to equity has declined by 31% year-on-year and by 24% since the previous quarter
The equity has grown by 30% from the previous quarter and by 26% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.